Development of Nanocrystal Compressed Minitablets for Chronotherapeutic Drug Delivery.
Ontology highlight
ABSTRACT: The present work aimed to develop a chronotherapeutic system of valsartan (VS) using nanocrystal formulation to improve dissolution. VS nanocrystals (VS-NC) were fabricated using modified anti-solvent precipitation by employing a Box-Behnken design to optimize various process variables. Based on the desirability approach, a formulation containing 2.5% poloxamer, a freezing temperature of -25 °C, and 24 h of freeze-drying time can fulfill the optimized formulation's requirements to result in a particle size of 219.68 nm, 0.201 polydispersity index, and zeta potential of -38.26 mV. Optimized VS-NC formulation was compressed (VNM) and coated subsequently with ethyl cellulose and HPMC E 5. At the same time, fast dissolving tablets of VS were designed, and the best formulation was loaded with V
SUBMITTER: Sreeharsha N
PROVIDER: S-EPMC8950040 | biostudies-literature | 2022 Mar
REPOSITORIES: biostudies-literature
ACCESS DATA